Skip to content
StockMarketAgent
Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

CSE/AIDR stock hub

CSE/AIDR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

CSE/AIDRis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
59M
Canadian Securities Exchange
Market data

Live price

Current market quote for this ticker.

Current price
CSE/AIDR
In the news

Latest news · CSE/AIDR

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11P50 15.6P75 25.4
Trailing P/En/a
P25 7.4P50 15.6P75 34.3
ROEn/a
P25 -121.5P50 -40.9P75 0.5
ROICn/a
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All CSE/AIDR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
143
Groups with data
11
Currency
CAD
Showing 143 of 143 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

17
MetricValue
Country
Canada
Country code
CA
Employees Change
0%
Employees Change Percent
0
Exchange
Canadian Securities Exchange
Financial currency
CAD
First seen
2026-05-10
Industry
Health Information Services
Isin
CA7729241066
Last refreshed
2026-05-10
Market cap
CAD 59M
Price
CAD 0.61
Price currency
CAD
Sector
Healthcare
Sic
7372
Symbol
cse/AIDR
Website
https://www.treatment.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-3.4%
P/B ratio
-88.76x
P/S ratio
1,548.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Gross margin
63.43%
Gross Profit
CAD 24,190
Net Income
CAD -2M
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Pretax Margin
-5,268.63%
ROA
-221.3
Roa5y
-516
ROCE
291.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
Cagr1y
58.49%
Cagr3y
20.34%
Cagr5y
-60.06%
EPS Growth Quarters
1
EPS Growth Years
3
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Asset Turnover
CAD 0.07
Assets
CAD 1M
Cash
CAD 897,393
Current Assets
CAD 2.7M
Current Liabilities
CAD 1.5M
Debt
CAD 609,171
Equity
CAD -665,178
Interest Coverage
-21.7
Liabilities
CAD 1.7M
Long Term Assets
CAD -1.7M
Long Term Liabilities
CAD 191,442
Net Cash
CAD 288,222
Net Cash By Market Cap
CAD 0.49
Tangible Book Value
CAD -665,178
Tangible Book Value Per Share
CAD -0.02
WACC
2.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
0.61
Net Working Capital
CAD -953,400
Quick ratio
0.54
Working Capital
CAD -665,178
Working Capital Turnover
CAD -0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-78.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
58.44%
200-day SMA
0.69
3Y total return
74.29%
50-day SMA
0.61
50-day SMA vs 200-day SMA
50under200
5Y total return
-98.98%
All Time High
63
All Time High Change
-99.03%
All Time High Date
2021-05-20
All Time Low
0.1
All Time Low Change
510%
All Time Low Date
2023-05-23
ATR
0.05
Beta
-0.4
Beta1y
0.39
Beta2y
0.71
Ch YTD
-16.44
High
0.64
High52
0.98
High52 Date
2025-11-07
High52ch
-37.76%
Low
0.59
Low52
0.33
Low52 Date
2025-06-09
Low52ch
84.85%
Ma50ch
-0.29%
Price vs 200-day SMA
-11.72%
RSI
49.23
RSI Monthly
23.96
RSI Weekly
45.47
Sharpe ratio
0.9x
Sortino ratio
1.78
Total Return
-78.95%
Tr YTD
-16.44
Tr1m
3.39%
Tr1w
1.67%
Tr3m
-21.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
CAD -1.9M
Operating margin
-5,080.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
92,840,618%
Net Borrowing
31,320
Shares Insiders
3.98%
Shares Institutions
0.25%
Shares Out
96,792,386
Shares Qo Q
437.87%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

41
MetricValue
Average Volume
177,066.05x
Bv Per Share
-0.02
Ch1m
3.39
Ch1w
1.67
Ch1y
58.44
Ch3m
-21.79
Ch3y
74.29
Ch5y
-98.98
Ch6m
-35.11
Change
-3.17%
Change From Open
-1.61
Close
0.63
Days Gap
-1.59
Dollar Volume
200,159.3
Earnings Date
2026-05-01
EBIT
CAD -1.9M
EPS
CAD -0.17
F Score
2
Financing CF
1,028,820
Fiscal Year End
December
Founded
2,018
Is Primary Listing
1
Last Earnings Date
2025-12-05
Last Report Date
2024-03-31
Last Split Date
2023-07-14
Last Split Type
Reverse
Ma150
0.72
Ma150ch
-15.38%
Ma20
0.62
Ma20ch
-1.85%
Net CF
847,614
Open
0.62
Position In Range
40
Price Date
2026-05-08
Relative Volume
1.93x
Revenue
38,136x
SBC By Revenue
883.77x
Share Based Comp
337,033
Tr6m
-35.11%
Volume
328,130
Z Score
-39.52
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does CSE/AIDR pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/AIDR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+58.4%
S&P 500 1Y: n/a
3Y total return
+74.3%
S&P 500 3Y: n/a
5Y total return
-99.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns CSE/AIDR?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.3%
Share of float held by funds and institutions
Insider ownership
+4.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

CSE/AIDR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
49.2
Neutral momentum band
Price vs 200-day MA
-11.7%
50/200-day relationship not available
Beta (5Y)
-0.40
Less volatile than the market
Sharpe ratio
0.90
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About CSE/AIDR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/AIDR stock rating?

cse/AIDR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/AIDR analysis?

The full report lives at /stocks/cse/AIDR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/AIDR?

The latest report frames cse/AIDR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/AIDR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

cse/AIDR stock profile: metrics, valuation and analysis | StockMarketAgent.AI